Skip to main navigation Skip to search Skip to main content

ACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico LIRICO "Long-term Impact of RAS Inhibition on Cardiorenal Outcomes-LIRICO"

Translated title of the contribution: Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes trial
  • A. Maione
  • , A. Nicolucci
  • , J. C. Craig
  • , G. Tognoni
  • , A. Moschetta
  • , G. Palasciano
  • , G. Pugliese
  • , D. A. Procaccini
  • , L. Gesualdo
  • , F. Pellegrini
  • , G.F.M. Strippoli

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)
Translated title of the contributionAngiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes trial
Original languageItalian
Pages (from-to)446-456
Number of pages11
JournalGiornale Italiano di Nefrologia
Volume24
Issue number5
Publication statusPublished - 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this